article · Scientific Reports
Lung cancer remains a leading cause of cancer-related mortality worldwide, highlighting the urgent need for more effective and safer therapeutic strategies. In this study, we investigated the potential of green-synthesized gold nanoparticles (AuNPs) conjugated with pheophorbide-a (Pheo-a) to enhance photodynamic therapy (PDT) efficacy against A549 lung cancer cells. The AuNPs-Pheo-a nanoconjugate demonstrated excellent physicochemical stability, minimal dark toxicity, and pronounced light-activated cytotoxicity in a concentration-dependent manner. Comprehensive in vitro evaluations revealed significant reductions in cell viability and metabolic activity, accompanied by increased apoptotic cell death following laser irradiation, while negligible effects were observed under dark conditions. Importantly, the nanoconjugate exhibited strong photodynamic selectivity toward cancer cells, underscoring its therapeutic potential. Overall, these findings demonstrate that green-synthesized AuNPs-Pheo-a represent a promising, biocompatible, and sustainable nanoplatform for photodynamic therapy in lung cancer, warranting further preclinical investigation.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1038/s41598-026-40697-y
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.